RetinalGenix Technologies (RTGN) Share-based Compensation Growth (3y) (2023 - 2026)
RetinalGenix Technologies (RTGN) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 3.40% |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 2.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.69% |
| Dec 31, 2025 | -21.72% |
| Sep 30, 2025 | 57.70% |
| Jun 30, 2025 | 65.64% |
| Mar 31, 2025 | 61.51% |
| Dec 31, 2024 | 245.42% |
| Sep 30, 2024 | 75.24% |
| Jun 30, 2024 | 34.70% |
| Mar 31, 2024 | 149.56% |
| Dec 31, 2023 | 37.75% |